You searched for viral vector - Page 24 of 53

Best in Biotech 15 May 2018

Here Are 10 of the Hottest Biotech Hubs in Europe

…a startup hub within the tech world, which also extends to biotech startups, such as ImmunoLogik, which aims to stop HIV from becoming resistant to antiretroviral therapy, or Solaga, which…

May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 8 Apr 2025

13 anti-aging startups on a mission to extend lives

…development called GF-1002, which is a suspension of a gene therapy for intravenous infusion. The company’s approach is to use adeno-associated virus vector-based (AAV) vectors to deliver copies of the…

April 8, 2025 - 19 minutesmins - By Willow Shah-Neville

News and Trends 6 Nov 2017

Austrian Biotech’s Vaccine Against Tropical Virus Moves Nicely Through Phase II

…vaccine that expresses antigens from the Chikungunya virus. The vaccine delivers the viral antigens directly to macrophages and dendritic cells, which triggers a strong immune response. The vector is able…

November 6, 2017 - 3 minutesmins - By Alex Dale

In Depth 4 Apr 2024

Seven diseases CRISPR technology could cure

…of repetitive patterns found in the DNA of bacteria that form the basis of a primitive immune system, defending them from viral invaders by cutting their DNA. Using this natural…

April 4, 2024 - 11 minutesmins - By Clara Rodríguez Fernández

coronavirus COVID 19 Europe biotech lungs

News and Trends 21 Jul 2022

Additional funding for trial to study drug targeting lung immunity in elderly patients

…is also anticipated to provide protection against future viral pandemics, seasonal influenza, and a wide range of other viral and bacterial infections. Additionally, given the role of innate immunity in…

July 21, 2022 - 3 minutesmins - By Liza Laws

In Depth 7 Jun 2021

The Post-Covid Future of AI for Drug Development

…affects viral entry or viral replication.” “Using our knowledge graph, we could ask those sorts of questions, pull out compounds, and interrogate the pathways that could lead to identifying those…

June 7, 2021 - 11 minutesmins - By Matthew Williams

Oryx glioblastoma ParvOryx combination 1

News and Trends 23 May 2017

German Biotech Tops Up its Oncolytic Virus with Immuno-Oncology Drugs

…its oncolytic viral therapy, ParvOryx, in combination with Roche’s VEGF-antibody bevacizumab and/or with immune checkpoint inhibitors Keytruda (Merck) or Opdivo (BMS). The promising results have encouraged Oryx to start up…

May 23, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 7 Feb 2023

AAHI bags $9.9M to develop nasal spray influenza RNA vaccine

…Current mRNA vaccines against COVID-19 reduce severe illness and hospitalization, but they require boosters to maintain protection, are not always effective against viral variants, and do not effectively curtail viral…

February 7, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 18 Oct 2022

Emergex develops vaccine for smallpox and monkeypox

…cells to recognize and destroy viral-infected cells. The fact that the vaccine construct’s pathogen peptides come from the “eclipse phase” of viral replication plays a key role in infection kinetics. …

October 18, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Aug 2018

Update: Seaweed-Derived Treatment for Common Cold Approved in the EU

…symptom-relieving nasal decongestant. Marinomed Biotechnology, based in Vienna, specializes in antiviral and immunological treatments based on polymers found in red seaweed. The company tested the efficacy of its antiviral treatment,…

August 7, 2018 - 2 minutesmins - By Alexander Burik

In Depth 30 Dec 2020

A Look Back at the Past Decade of European Biotech

…checkpoint inhibitor drugs, the first oncolytic viral therapy, and the approval of the first CAR-T cell therapies. For Alexandra Bause, who leads a venture creation program at the investment firm…

December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt

News and Trends 16 Mar 2017

Researchers Develop New Virus to Selectively Attack Tumor Cells

…have inserted sequences into the genome of an adenovirus, which recognize CPEB proteins. With this strategy, they achieved attenuated viral activity in normal cells, while in tumor cells the virus…

March 16, 2017 - 3 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Here Are 10 of the Hottest Biotech Hubs in Europe

13 anti-aging startups on a mission to extend lives

Austrian Biotech’s Vaccine Against Tropical Virus Moves Nicely Through Phase II

Seven diseases CRISPR technology could cure

Additional funding for trial to study drug targeting lung immunity in elderly patients

The Post-Covid Future of AI for Drug Development

German Biotech Tops Up its Oncolytic Virus with Immuno-Oncology Drugs

AAHI bags $9.9M to develop nasal spray influenza RNA vaccine

Emergex develops vaccine for smallpox and monkeypox

Update: Seaweed-Derived Treatment for Common Cold Approved in the EU

A Look Back at the Past Decade of European Biotech

Researchers Develop New Virus to Selectively Attack Tumor Cells

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!